Pages that link to "Q24609011"

The following pages link to Dose adjustment of the non-nucleoside reverse transcriptase inhibitors during concurrent rifampicin-containing tuberculosis therapy: one size does not fit all (Q24609011):

Displaying 18 items.

• Comparative study of the effects of antituberculosis drugs and antiretroviral drugs on cytochrome P450 3A4 and P-glycoprotein (Q33797986) (← links)
• Unresolved antiretroviral treatment management issues in HIV-infected children (Q36781481) (← links)
• Lack of association between plasma levels of non-nucleoside reverse transcriptase inhibitors & virological outcomes during rifampicin co-administration in HIV-infected TB patients (Q37690861) (← links)
• Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 1: first-line drugs (Q37810480) (← links)
• Pharmacokinetic optimization of antiretroviral therapy in children and adolescents (Q37835819) (← links)
• Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients (Q37845854) (← links)
• Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges (Q37866289) (← links)
• CYP2B6 genotype, but not rifampicin-based anti-TB cotreatments, explains variability in long-term efavirenz plasma exposure (Q38861140) (← links)
• Is there a need to increase the dose of efavirenz during concomitant rifampicin-based antituberculosis therapy in sub-Saharan Africa? The HIV-TB pharmagene study (Q39039468) (← links)
• Long-Term Effect of Rifampicin-Based Anti-TB Regimen Coadministration on the Pharmacokinetic Parameters of Efavirenz and 8-Hydroxy-Efavirenz in Ethiopian Patients (Q40694902) (← links)
• Efficacy and Safety of Once-Daily Nevirapine- or Efavirenz-Based Antiretroviral Therapy in HIV-Associated Tuberculosis: A Randomized Clinical Trial (Q42615157) (← links)
• Current Use for Old Antibacterial Agents: Polymyxins, Rifamycins, and Aminoglycosides (Q44328993) (← links)
• When to start, what to start and other treatment controversies in pediatric HIV infection (Q44986291) (← links)
• Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high HIV and tuberculosis burden countries: a systematic review. (Q52330065) (← links)
• Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial (Q59650851) (← links)
• Conference report: pharmacogenomics in special populations at WCP2018 (Q90404370) (← links)
• State-of-the-Art Review of HIV-TB Coinfection in Special Populations (Q91102503) (← links)
• In Vitro Assessment of the Interaction Potential of Ocimum basilicum (L.) Extracts on CYP2B6, 3A4, and Rifampicin Metabolism (Q95270356) (← links)